ENTRY       D00387                      Drug
NAME        Triazolam (JP18/USP/INN);
            Halcion (TN)
PRODUCT     HALCION (Pharmacia & Upjohn Company LLC)
  GENERIC   TRIAZOLAM (A-S Medication Solutions)
            TRIAZOLAM (A-S Medication Solutions)
            TRIAZOLAM (Aphena Pharma Solutions - Tennessee)
            TRIAZOLAM (Bryant Ranch Prepack)
            TRIAZOLAM (Greenstone LLC)
            TRIAZOLAM (Hikma Pharmaceuticals USA)
            TRIAZOLAM (Ingenus Pharmaceuticals)
            TRIAZOLAM (PD-Rx Pharmaceuticals)
            TRIAZOLAM (PD-Rx Pharmaceuticals)
            TRIAZOLAM (Zydus Lifesciences Limited)
            TRIAZOLAM (Zydus Pharmaceuticals USA)
FORMULA     C17H12Cl2N4
EXACT_MASS  342.0439
MOL_WEIGHT  343.21
CLASS       Neuropsychiatric agent
             DG01835  Benzodiazepine sedative-hypnotics
             DG03202  Hypnotic
             DG01567  GABA-A receptor agonist
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 1124
            ATC code: N05CD05
            Product: D00387<JP/US>
EFFICACY    Sedative-hypnotic
  DISEASE   Insomnia [DS:H01609]
COMMENT     Benzodiazepine derivative
TARGET      GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]
  PATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction
            hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07032  Hypnotics
            map07230  GABA-A receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05C HYPNOTICS AND SEDATIVES
                N05CD Benzodiazepine derivatives
                 N05CD05 Triazolam
                  D00387  Triazolam (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Sleep Disorder Agents
              Sleep Promoting Agents
               Triazolam
                D00387  Triazolam (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               112  Hypnotics and sedatives, anxiolytics
                1124  Benzodiazepins
                 D00387  Triazolam (JP18/USP/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01835  Benzodiazepine sedative-hypnotics
               D00387  Triazolam
              DG03202  Hypnotic
               D00387  Triazolam
              DG01567  GABA-A receptor agonist
               D00387  Triazolam
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D00387  Triazolam
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03202  Hypnotic
               D00387  Triazolam
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Ligand-gated ion channels
               GABA (ionotropic)
                GABR
                 D00387  Triazolam (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00387  Triazolam
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00387
            Narcotics and psychotropics in Japan [br08308.html]
             Psychotropics by Cabinet order Article 3 (78 substances)
              D00387
DBLINKS     CAS: 28911-01-5
            PubChem: 7847453
            ChEBI: 9674
            LigandBox: D00387
            NIKKAJI: J9.291F
ATOM        23
            1   C2y C    22.2631  -15.9778
            2   C8y C    21.4204  -14.7974
            3   C8y C    21.7559  -13.4397
            4   N4y N    23.0177  -12.8611
            5   N2x N    23.6699  -15.9330
            6   C8y C    24.2722  -13.4839
            7   C1x C    24.5589  -14.8536
            8   C8x C    20.7480  -12.4706
            9   C8x C    19.4051  -12.8589
            10  C8y C    19.0697  -14.2167
            11  C8x C    20.0775  -15.1855
            12  X   Cl   17.7039  -14.6114
            13  C8y C    21.6282  -17.1584
            14  C8x C    20.2256  -17.1584
            15  C8x C    19.5251  -18.3717
            16  C8x C    20.2256  -19.5850
            17  C8x C    21.6282  -19.5850
            18  C8y C    22.3287  -18.3717
            19  X   Cl   23.7406  -18.3718
            20  N5x N    25.2522  -12.4832
            21  N5x N    24.6033  -11.2420
            22  C8y C    23.2224  -11.4756
            23  C1a C    22.2334  -10.5070
BOND        26
            1     3   4 1
            2     1   5 2
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     3   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    2  11 2
            13   10  12 1
            14    1  13 1
            15   13  14 1
            16   14  15 2
            17   15  16 1
            18   16  17 2
            19   17  18 1
            20   13  18 2
            21   18  19 1
            22    6  20 2
            23   20  21 1
            24   21  22 2
            25    4  22 1
            26   22  23 1
///
